PGFC
MACK

Peapack-Gladstone Financial Corp’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,366
Closed -$128K – 338
2015
Q1 		$128K Hold
1,366
– – 0.01% 323
2014
Q4 		$121K Sell
1,366
-318
-19% -$23.2K 0.01% 300
2014
Q3 		$116K Sell
1,684
-642
-28% -$34.3K 0.01% 289
2014
Q2 		$133K Sell
2,326
-170
-7% -$8.63K 0.01% 286
2014
Q1 		$99K Sell
2,496
-725
-23% -$31K 0.01% 286
2013
Q4 		$135K Sell
3,221
-2,987
-48% -$86.6K 0.01% 277
2013
Q3 		$185K Hold
6,208
– – 0.02% 273
2013
Q2 		$329K Buy
+6,208
New +$272K 0.03% 225

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Peapack-Gladstone Financial Corp's MACK Position: Q2 2015 in Review

Peapack-Gladstone Financial Corp sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2015, closing a stake of 1,366 shares — an estimated $128K sold.

Peapack-Gladstone Financial Corp first reported a position in MACK in Q2 2013 and held it in 8 quarters. The position peaked at $329K in Q2 2013. 150 funds tracked by Wall St. Rank hold MACK as of Q2 2015.

  • Peapack-Gladstone Financial Corp reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Peapack-Gladstone Financial Corp sold 1,366 Merrimack Pharmaceuticals, Inc. shares in Q2 2015, an estimated $128K.
  • Peapack-Gladstone Financial Corp first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 8 quarters.
  • Peapack-Gladstone Financial Corp's Merrimack Pharmaceuticals, Inc. position peaked at $329K in Q2 2013.
  • 150 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2015.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2015, filed 13 Aug 2015.